1. Pink Sheet
  2. >>Geography

Italian Regulator Promotes Availability Of Potential COVID-19 Treatments

Remdesivir, Kaletra & Actemra Are In The Frame

 
• By Ian Schofield

Italy has so far borne the brunt of Europe’s growing coronavirus outbreak. Now it is offering patients the chance to access unauthorized medicines as part of efforts to stem the outbreak.

Microscopic view of Coronavirus, a pathogen that attacks the respiratory tract. Analysis and test, experimentation. Sars. 3d render
Italy is easing access to potential COVID-19 therapies • Source: Shutterstock

The Italian medicines agency, AIFA, has set up a COVID-19 “crisis unit” to oversee the provision of certain medicines for use against the outbreak, either in clinical trials or as off-label use, including Gilead Sciences Inc.’s investigational antiviral, remdesivir, and AbbVie Inc.’s antiviral combination product, Kaletra (lopinavir/ritonavir).

Efforts are also under way to give patients access to other potential therapies such as Roche’s anti-inflammatory antibody Actemra

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Italy

More from Europe